Clinical Trial Update: Antibody Titer Analysis After H1N1 Vaccination in Pediatric Haemato-oncology Patients

View source ↗

Summary

A clinical trial update reporting antibody titer analysis after H1N1 vaccination in children with hematology-oncology conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Childhood Cancer
• Hematologic Neoplasms

Drugs mentioned

• H1N1 influenza vaccine (Influenza A/H1N1 vaccine)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Serology Analysis, Novel H1N1 Influenza Vaccination | Status: UNKNOWN